Javier Molina‐Cerrillo

Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)

Mechanisms of hypoxia signalling: new implications for nephrology

Macrophages in immunoregulation and therapeutics

COVID-19: A promising cure for the global panic

The tumor microenvironment

Inflammation and tumor progression: signaling pathways and targeted intervention

Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

Translational repression of HIF2α expression in mice with Chuvash polycythemia reverses polycythemia

Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses

B cells, plasma cells and antibody repertoires in the tumour microenvironment

NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis

The B-Side of Cancer Immunity: The Underrated Tune

Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy

Bruton’s tyrosine kinase (BTK) as a promising target in solid tumors